Link Björn-Christian, Yekebas Emre F, Bogoevski Dean, Kutup Asad, Adam Gerhard, Izbicki Jakob R, Krupski Gerrit
Department of General, Visceral and Thoracic Surgery, University Medical Center of Hamburg-Eppendorf, Martinistr. 52, 20246 Hamburg, Germany.
J Gastrointest Surg. 2007 Feb;11(2):166-70. doi: 10.1007/s11605-006-0074-y.
Symptomatic biliary leakage following major upper abdominal surgery is a severe complication resulting in increased morbidity and mortality. Treatment options usually include either endoscopic intervention or surgical revision. These options may be burdened by a high perioperative risk for the patient (e.g., patients with severe disease) or simply may not be possible (e.g., nonpreserved gastroduodenal passage). In the past, percutaneous transhepatic cholangiodrainage did only seem to be a viable option for patients with dilated bile ducts. Here, we present our experience in a consecutive series of patients with symptomatic biliary leakage following major upper abdominal surgery and without dilation of the biliary system that underwent percutaneous transhepatic cholangiodrainage. Percutaneous transhepatic cholangiodrainage was feasible in 15 of 18 patients (83.3%). The procedure was technically not possible in three patients (16.7%). In 10 of the 15 patients (66.6%) with feasible percutaneous transhepatic cholangiodrainage, biliary leakage was definitely controlled without the need for surgical revision. Depending on the experience with the interventional procedure, percutaneous transhepatic cholangiodrainage should be considered as an alternative for treatment of symptomatic biliary leakage instead of immediate reoperation.
上腹部大手术后出现的症状性胆漏是一种严重并发症,会导致发病率和死亡率上升。治疗选择通常包括内镜干预或手术修复。这些选择可能因患者围手术期风险高(如患有严重疾病的患者)而受到影响,或者根本无法实施(如胃十二指肠通道未保留)。过去,经皮经肝胆道引流似乎仅对胆管扩张的患者是一种可行的选择。在此,我们介绍我们对一系列连续的上腹部大手术后出现症状性胆漏且胆道系统未扩张并接受经皮经肝胆道引流患者的经验。18例患者中有15例(83.3%)经皮经肝胆道引流可行。3例患者(16.7%)技术上无法进行该操作。在15例经皮经肝胆道引流可行的患者中,有10例(66.6%)胆漏得到明确控制,无需手术修复。根据介入操作的经验,经皮经肝胆道引流应被视为治疗症状性胆漏的一种替代方法,而非立即再次手术。